Maintenance with ivosidenib post-HCT in IDH1-mutated AML

06.06.23

Maintenance with ivosidenib post-HCT in IDH1-mutated AML

by ASTCT Science Highlights

Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology

05.12.23

Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology

by Alex Kadhim

Controlling ambient oxygen levels reduces severity of GI GVHD in murine models

05.11.23

Controlling ambient oxygen levels reduces severity of GI GVHD in murine models

by ASTCT Science Highlights

Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation

05.10.23

Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation

by Alex Kadhim

A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease

05.04.23

A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease

by Alex Kadhim

Donor lymphocytes engineered with SA-FasL to avoid aGVHD

04.20.23

Donor lymphocytes engineered with SA-FasL to avoid aGVHD

by ASTCT Science Highlights

$Abatacept for steroid-refractory cGVHD$

04.18.23

Abatacept for steroid-refractory cGVHD

by ASTCT Science Highlights

CD83 is a Promising GVHD Biomarker and Therapeutic Target

04.05.23

CD83 is a Promising GVHD Biomarker and Therapeutic Target

by Alex Kadhim

The Importance of Donor Age Over Donor Type

03.30.23

The Importance of Donor Age Over Donor Type

by Alex Kadhim

Theme picker